Literature DB >> 2530320

Transluminal angioplasty for treatment of intracranial arterial vasospasm.

R T Higashida1, V V Halbach, L D Cahan, M Brant-Zawadzki, S Barnwell, C Dowd, G B Hieshima.   

Abstract

Percutaneous transluminal angioplasty for treatment of intracerebral arterial vasospasm is now being performed in selected cases. Thirty-six vascular territories in 13 patients, ranging in age from 15 to 73 years, have been treated with a new silicone microballoon device. This balloon has allowed mechanical dilatation of segmental and diffuse areas of spastic intracerebral blood vessels less than 1 mm in diameter with return to normal luminal diameter. Follow-up angiography has documented improved cerebral perfusion without return of spasm. In 10 patients (77%), vasospasm was due to subarachnoid hemorrhage following rupture of an intracranial aneurysm. In three patients (23%), spasm with resultant neurological decline occurred during detachable balloon embolization therapy for treatment of an aneurysm. In each case, the vessel caliber returned to normal size following balloon dilatation. In nine (69%) of the 13 cases, balloon dilatation resulted in improvement of neurological function within minutes to hours following the procedure. Transluminal angioplasty techniques may offer an alternative form of therapy in the management of symptomatic arterial vasospasm.

Entities:  

Mesh:

Year:  1989        PMID: 2530320     DOI: 10.3171/jns.1989.71.5.0648

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  20 in total

1.  Mechanical and pharmacologic treatment of vasospasm.

Authors: 
Journal:  AJNR Am J Neuroradiol       Date:  2001-09       Impact factor: 3.825

Review 2.  Therapeutic advances in interventional neurology.

Authors:  Jawad F Kirmani; Nazli Janjua; Ammar Al Kawi; Shafiuddin Ahmed; Ismail Khatri; Ali Ebrahimi; Afshin A Divani; Adnan I Qureshi
Journal:  NeuroRx       Date:  2005-04

3.  Subarachnoid hemorrhage in the African-American population: a cooperative study.

Authors:  G C Dennis; B Welch; A N Cole; R Mendoza; J Morgan; J Epps; E Bernard; P St Louis
Journal:  J Natl Med Assoc       Date:  1997-02       Impact factor: 1.798

4.  Biomechanical effects of experimental transluminal angioplasty.

Authors:  V Keris; V Kasyanov; G Enina
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

5.  Reversible cerebral vasoconstriction syndrome: treatment with combined intra-arterial verapamil infusion and intracranial angioplasty.

Authors:  H Farid; J K Tatum; C Wong; V V Halbach; S W Hetts
Journal:  AJNR Am J Neuroradiol       Date:  2011-01-27       Impact factor: 3.825

Review 6.  Treatment options for cerebral vasospasm in aneurysmal subarachnoid hemorrhage.

Authors:  M Kamran Athar; Joshua M Levine
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

7.  Balloon angioplasty immediately after surgical clipping for symptomatic vasospasm on admission. Report of four cases.

Authors:  Y Fujii; A Takahashi; M Ezura; K Mizoi
Journal:  Neurosurg Rev       Date:  1995       Impact factor: 3.042

Review 8.  Critical care management of subarachnoid hemorrhage.

Authors:  Joshua M Levine
Journal:  Curr Neurol Neurosci Rep       Date:  2008-11       Impact factor: 5.081

9.  Critical care management of subarachnoid hemorrhage.

Authors:  Joshua M Levine
Journal:  Curr Treat Options Neurol       Date:  2009-03       Impact factor: 3.598

10.  Intravascular balloon dilatation therapy for intracranial arterial vasospasm: patient selection, technique, and clinical results.

Authors:  R T Higashida; V V Halbach; C F Dowd; B Dormandy; J Bell; G B Hieshima
Journal:  Neurosurg Rev       Date:  1992       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.